From purines to purinergic signalling: molecular functions and human diseases (2021)
Huang, Zhao; Xie, Na; Illes, Peter; Virgilio, Francesco Di 
; Ulrich, Henning ; Semyanov, Alexey ; Verkhratsky, Alexei; Sperlagh, Beata; Yu, Shu-Guang; Huang, Canhua ; Tang, Yong
Fonte: Signal Transduction and Targeted Therapy. Unidade: IQ
Assuntos: PURINAS, DOENÇAS NEURODEGENERATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUANG, Zhao et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, v. 6, p. 1-20 art. 162, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41392-021-00553-z. Acesso em: 02 jul. 2024.APA
Huang, Z., Xie, N., Illes, P., Virgilio, F. D., Ulrich, H., Semyanov, A., et al. (2021). From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6, 1-20 art. 162. doi:10.1038/s41392-021-00553-zNLM
Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1038/s41392-021-00553-zVancouver
Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
